Whether or not this is the year that some of the biggest AI IPOs hit the public markets, there’s certainly a packed pipeline ...

Analysts are cautiously optimistic about an IPO rebound for biopharma. BioSpace is keeping track of companies that seek to ...

In 2025, the initial public offering (IPO) market continued to rebound from the 2022 and 2023 slump. For the second year in a row, markets saw more IPOs, more special purpose acquisition companies ...

Coatue Management's founder and portfolio manager said the market today bears little resemblance to the vibrant IPO pipeline of prior decades. "Twenty or 30 years ago, there were so many more IPOs ...

SoftBank-backed Lenskart had a muted debut on the exchanges as its shares traded down 11% at the open. The issue was subscribed to over 28 times, with strong participation from institutional investors ...

Why the IPO market took off in 2025. In this podcast, Motley Fool analysts Emily Flippen and Sanmeet Deo and contirubtor Jason Hall break down why the IPO market took off in 2025, which new listings ...

Aktis Oncology exceeded its own expectations for its IPO in a good omen for those hoping for a more inviting public market this year. The company, which has accrued an impressive list of Big Pharma ...

Medline shares surged more than 40% in their hotly anticipated New York debut on Wednesday, valuing the medical supply giant at $54 billion in the largest US initial public offering since Rivian’s ...

Navan, the corporate travel and expense platform, finished its first day of trading on the Nasdaq on Thursday down 20% from its $25 IPO price, resulting in a valuation of approximately $4.7 billion ...

Medline Inc. completed a record-setting $6.26B IPO, allocating proceeds primarily to reduce leveraged buyout debt from 2021. MDLN operates globally with $20.6B YTD revenue, stable 10% growth, and ...

One is the largest private space company the world has ever seen. The other is a cryptocurrency exchange operator with a significant competitive edge. Investors should be able to own shares of both ...

Coming into this year, there was a lot of optimism that this would be a strong year for initial public offerings (IPOs), and that optimism has been met — IPOs are back! And, as we’ll show, both the ...